News
Steering Committee Meeting
The ESPOIR Steering Committee Meeting took place on 30th of October 2012 in Barcelona at the 26th EACTS Annual Meeting. During the Scientific Programme Prof. Haverich gave an update on the “Clinical results with in vitro unseeded... [more]
Leuven new clinical partner within the ESPOIR study
Leuven with Prof. Dr. Bart Meyns, Head of Cardiac Surgery - Cardiale Heelkunde, University Hospitals, Katholieke Universiteit Leuven has been officially added by the European Commission to the ESPOIR project partners. Prof.... [more]
Ten years of innovative heart valves from Hannover
Bright eyes and happy smiles on the faces of children, young people and adults alike are nothing unusual at Hannover Adventure Zoo. On Saturday, however, it was a very special group that met at the zoo to have fun together:... [more]
Welcome to ESPOIR
Beginning in January 2012, the European Union will fund the European Clinical Study for the Application of Regenerative Heart Valves (ESPOIR) trial, coordinated by the Hannover Medical School, Germany, with a grant of 5.2 Million Euros for a period of four years. The aim of ESPOIR is to transplant a heart valve, which is tolerated by the patient’s immune system, lasts a lifetime and, for children, even holds the potential to grow with the patient.